We should be negotiating all drug prices, not just the 13 drug prices that were negotiated under the I.R.A.
Negotiate all drug prices.
Occurrences
Evidence
CMS lists selected-drug cohorts for 2026, 2027, and 2028, including 10 first-cycle drugs, 15 second-cycle drugs, and 15 third-cycle drugs. CMS says third-cycle negotiations occur in 2026 and any prices take effect in 2028.
The Supreme Court order list under certiorari denied includes AstraZeneca, Janssen, Bristol Myers Squibb, Novo Nordisk, and Boehringer Ingelheim challenges involving HHS or the Department of HHS.
Congress.gov says H.R.6166 would expand the drug price negotiation program, apply prescription drug inflation rebates to the commercial market, and establish out-of-pocket limits for private insurance; its tracker status remains Introduced after House committee referral.
Perez's office says she joined a bipartisan bill to bring down health care costs, including ending hidden spread pricing, severing PBM profits from drug prices, and requiring full rebate pass-through.
Assessments
The promise was to negotiate all drug prices, which has not been fully delivered. The federal Medicare negotiation program covers selected cohorts of Medicare drugs for 2026, 2027, and 2028, not all prescription drug prices, so the achieved policy is materially narrower than the claim. Perez has taken legislative action on drug affordability and related pricing reforms, but the broader all-drug negotiation outcome has not become law. Because there is a real but incomplete policy implementation and candidate effort toward the area, partial credit is appropriate rather than delivered or never.